These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27714705)

  • 1. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation.
    Aubron C; DePuydt J; Belon F; Bailey M; Schmidt M; Sheldrake J; Murphy D; Scheinkestel C; Cooper DJ; Capellier G; Pellegrino V; Pilcher D; McQuilten Z
    Ann Intensive Care; 2016 Dec; 6(1):97. PubMed ID: 27714705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal membrane oxygenation in the treatment of poisoned patients.
    de Lange DW; Sikma MA; Meulenbelt J
    Clin Toxicol (Phila); 2013 Jun; 51(5):385-93. PubMed ID: 23697460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure.
    Seeliger B; Döbler M; Friedrich R; Stahl K; Kühn C; Bauersachs J; Steinhagen F; Ehrentraut SF; Schewe JC; Putensen C; Welte T; Hoeper MM; Tiede A; David S; Bode C
    Crit Care; 2021 Jan; 24(1):701. PubMed ID: 33397427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
    Martucci G; Giani M; Schmidt M; Tanaka K; Tabatabai A; Tuzzolino F; Agerstrand C; Riera J; Ramanan R; Grasselli G; Ait Hssain A; Gannon WD; Buabbas S; Gorjup V; Trethowan B; Rizzo M; Fanelli V; Jeon K; De Pascale G; Combes A; Ranieri MV; Duburcq T; Foti G; Chico JI; Balik M; Broman LM; Schellongowski P; Buscher H; Lorusso R; Brodie D; Arcadipane A;
    Am J Respir Crit Care Med; 2024 Feb; 209(4):417-426. PubMed ID: 37943110
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.
    Cartwright B; Bruce HM; Kershaw G; Cai N; Othman J; Gattas D; Robson JL; Hayes S; Alicajic H; Hines A; Whyte A; Chaikittisilpa N; Southwood TJ; Forrest P; Totaro RJ; Bannon PG; Dunkley S; Chen VM; Dennis M
    Sci Rep; 2021 Apr; 11(1):7975. PubMed ID: 33846433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study.
    Moussa MD; Soquet J; Lamer A; Labreuche J; Gantois G; Dupont A; Abou-Arab O; Rousse N; Liu V; Brandt C; Foulon V; Leroy G; Schurtz G; Jeanpierre E; Duhamel A; Susen S; Vincentelli A; Robin E
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34067573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years.
    Richardson AS; Schmidt M; Bailey M; Pellegrino VA; Rycus PT; Pilcher DV
    Resuscitation; 2017 Mar; 112():34-40. PubMed ID: 27993632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study.
    Aubron C; Cheng AC; Pilcher D; Leong T; Magrin G; Cooper DJ; Scheinkestel C; Pellegrino V
    Crit Care; 2013 Apr; 17(2):R73. PubMed ID: 23594433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute neurological complications in adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation support.
    Laimoud M; Ahmed W
    Egypt Heart J; 2020 May; 72(1):26. PubMed ID: 32449052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lower extremity vascular complications in adult patients on veno-arterial extracorporeal membrane oxygenation.
    Siems C; Valentine RJ; Wang Q; Duke J; Brunsvold M; Reed AB
    J Vasc Surg; 2023 Apr; 77(4):1174-1181. PubMed ID: 36639061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study.
    Descamps R; Moussa MD; Besnier E; Fischer MO; Preau S; Tamion F; Daubin C; Cousin N; Vincentelli A; Goutay J; Du Cheyron D
    Crit Care; 2021 Apr; 25(1):127. PubMed ID: 33810800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial.
    Aubron C; Chapalain X; Bailey M; Board J; Buhr H; Cartwright B; Dennis M; Hodgson C; Forrest P; McIlroy D; Murphy D; Murray L; Pellegrino V; Pilcher D; Sheldrake J; Tran H; Vallance S; Cooper DJ; McQuilten Z
    Crit Care Explor; 2023 Nov; 5(11):e0999. PubMed ID: 37954899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Coagulation Parameters, Anticoagulation, and Need for Transfusion in Patients on Interventional Lung Assist or Veno-Venous Extracorporeal Membrane Oxygenation.
    Weingart C; Lubnow M; Philipp A; Bein T; Camboni D; Müller T
    Artif Organs; 2015 Sep; 39(9):765-73. PubMed ID: 25921195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new anticoagulation strategy using recombinant human thrombomodulin in patients on veno-venous extracorporeal membrane oxygenation: a retrospective study.
    Yasuda N; Goto K; Mizoguchi T; Ohchi Y; Nureki SI; Kitano T
    Ann Palliat Med; 2021 Feb; 10(2):1834-1841. PubMed ID: 33440963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Recovery in Critically Ill Adult Patients Treated with Veno-Venous Or Veno-Arterial Extra Corporeal Membrane Oxygenation: a Retrospective Cohort Analysis.
    Thyagarajan B; Murea M; Jones DN; Saha AK; Russell GB; Khanna AK
    J Crit Care Med (Targu Mures); 2021 Apr; 7(2):104-112. PubMed ID: 34722911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry.
    Smith M; Vukomanovic A; Brodie D; Thiagarajan R; Rycus P; Buscher H
    Crit Care; 2017 Mar; 21(1):45. PubMed ID: 28264702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation.
    Khalid N; Javed H; Ahmad SA; Edelman JJ; Shlofmitz E; Chen Y; Musallam A; Rogers T; Hashim H; Bernardo NL; Waksman R
    Cardiovasc Revasc Med; 2020 Feb; 21(2):230-234. PubMed ID: 31767523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.